A
Alfred K Lam
Researcher at Griffith University
Publications - 42
Citations - 287
Alfred K Lam is an academic researcher from Griffith University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 7, co-authored 24 publications receiving 136 citations. Previous affiliations of Alfred K Lam include Zhengzhou University.
Papers
More filters
Journal ArticleDOI
Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
TL;DR: This review summarizes the functional mechanism and use of various immune checkpoint molecules in HNSCC, including monotherapies and combination therapies, and provides better treatment options for patients with HNS CC.
Journal ArticleDOI
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance
Plabon Kumar Das,Suja Pillai,Abdur Rakib,Jahan Ara Khanam,Vinod Gopalan,Alfred K Lam,Farhadul Islam,Farhadul Islam +7 more
TL;DR: This review discusses how cancer cells acquire the plasticity, especially the role of the normal developmental process, tumour microenvironment, and epigenetic changes in the development of plasticity.
Journal ArticleDOI
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kyeong Jin Kim,Sin Gon Kim,Jie Tan,Xiaopei Shen,David Viola,Rossella Elisei,Efisio Puxeddu,Laura Fugazzola,Carla Colombo,Barbara Jarzab,Agnieszka Czarniecka,Alfred K Lam,Caterina Mian,Federica Vianello,Linwah Yip,Garcilaso Riesco-Eizaguirre,Pilar Santisteban,Christine J. O'Neill,Mark Sywak,Roderick J. Clifton-Bligh,Bela Bendlova,Vlasta Sýkorová,Mingzhao Xing +22 more
TL;DR: Given the robust negative predictive value, conservative active surveillance of BRAF mutation-negative low-risk PTMC is reasonable whereas the increased recurrence risk and other well-known adverse effects of BRAf V600E make the feasibility of long-term conservative surveillance uncertain for BRAf mutation-positive PTMC.
Journal ArticleDOI
Pancreatic neuroendocrine neoplasms: The latest surgical and medical treatment strategies based on the current World Health Organization classification.
Hirotaka Ishida,Alfred K Lam +1 more
TL;DR: To conclude, management of PanNENs depends on various factors and further development of treatment strategies is required for improvement of survival outcome of patients with PanN ENs.
Journal ArticleDOI
Squamous cell carcinoma of thyroid: a unique type of cancer in World Health Organization Classification
TL;DR: Primary squamous cell carcinoma of the thyroid gland has distinctive clinical, pathological and molecular profiles and it is important to recognize this unique variant of thyroid carcinoma for possible curative surgical resection.